Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Gynecologic oncology group trials in uterine corpus malignancies: recent progress.

Miller DS, King LP.

J Gynecol Oncol. 2008 Dec;19(4):218-22. doi: 10.3802/jgo.2008.19.4.218. Epub 2008 Dec 29.

2.

Recent progress: gynecologic oncology group trials in uterine corpus tumors.

King LP, Miller DS.

Rev Recent Clin Trials. 2009 May;4(2):70-4. Review.

PMID:
19463102
3.

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Galaal K, van der Heijden E, Godfrey K, Naik R, Kucukmetin A, Bryant A, Das N, Lopes AD.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD006812. doi: 10.1002/14651858.CD006812.pub3. Review.

PMID:
23450572
4.

Gynecological malignancies.

Schaebler DL, Schilder RJ, Young RC.

Cancer Chemother Biol Response Modif. 1996;16:564-91. Review.

PMID:
8639401
5.

Adjuvant chemotherapy for advanced endometrial cancer.

Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA.

Cochrane Database Syst Rev. 2014 May 15;(5):CD010681. doi: 10.1002/14651858.CD010681.pub2. Review.

PMID:
24832785
6.

Gynecologic malignancies.

Schilder RJ, Scher RM, Young RC.

Cancer Chemother Biol Response Modif. 1993;14:530-56. Review.

PMID:
8312118
7.

Progress in gynecologic cancer research: the Gynecologic Oncology Group experience.

Omura GA; Gynecologic Oncology Group.

Semin Oncol. 2008 Oct;35(5):507-21. doi: 10.1053/j.seminoncol.2008.07.007. Review.

8.

The management of patients with uterine sarcoma: a debated clinical challenge.

Gadducci A, Cosio S, Romanini A, Genazzani AR.

Crit Rev Oncol Hematol. 2008 Feb;65(2):129-42. Epub 2007 Aug 13. Review.

PMID:
17706430
9.

Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer.

Ozols RF.

Cancer Invest. 2004;22 Suppl 2:11-20. Review.

PMID:
15573741
10.

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, Leitao MM, Powell MA, Poveda A, Beale P, Glasspool RM, Creutzberg CL, Harter P, Kim JW, Reed NS, Ray-Coquard I.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S55-60. doi: 10.1097/IGC.0000000000000228. Review.

PMID:
25341582
11.

An update on the management of uterine carcinosarcoma.

Gurumurthy M, Somoye G, Cairns M, Parkin DE.

Obstet Gynecol Surv. 2011 Nov;66(11):710-6. doi: 10.1097/OGX.0b013e31823e0c44. Review.

PMID:
22186602
12.

Adjuvant treatment for stage IIIC endometrial cancer: options and controversies.

Shah PH, Kudrimoti M, Feddock J, Randall M.

Gynecol Oncol. 2011 Sep;122(3):675-83. doi: 10.1016/j.ygyno.2011.05.018. Epub 2011 Jun 12. Review.

PMID:
21664661
13.

Biomarkers as prognostic factors in endometrial cancer.

Dobrzycka B, Terlikowski SJ.

Folia Histochem Cytobiol. 2010 Sep 30;48(3):319-22. doi: 10.2478/v10042-10-0061-8. Review.

14.

Postoperative irradiation in endometrial cancer: still a matter of controversy.

Jereczek-Fossa BA.

Cancer Treat Rev. 2001 Feb;27(1):19-33. Review.

PMID:
11237775
15.

Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes.

Mendivil A, Schuler KM, Gehrig PA.

Cancer Control. 2009 Jan;16(1):46-52. Review.

16.

Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.

Tewari KS, Monk BJ.

Semin Oncol. 2009 Apr;36(2):170-80. doi: 10.1053/j.seminoncol.2008.12.008. Review.

PMID:
19332251
17.

Perspectives on research in gynecologic oncology.

DeVita VT Jr, Wasserman TH, Young RC, Carter SK.

Cancer. 1976 Jul;38(1 SUPPL):509-25. Review.

18.

Advances in the treatment of gynecologic malignancies. Part 2: Cancers of the uterine corpus and ovary.

Kim RY, Omura GA, Alvarez RD.

Oncology (Williston Park). 2002 Dec;16(12):1669-78; discussion 1678-80. Review.

19.

The role of adjuvant radiation in endometrial cancer.

Diavolitsis V, Boyle J, Singh DK, Small W Jr.

Oncology (Williston Park). 2009 Apr 15;23(4):342-9. Review.

20.

Therapeutic dilemmas in the management of uterine papillary serous carcinoma.

Lackman FD, Craighead PS.

Curr Treat Options Oncol. 2003 Apr;4(2):99-104. Review.

PMID:
12594935

Supplemental Content

Support Center